ITMCTR2000003925招募中1 期
Chai-Yin particles in the treatment of mild flu randomized, double-blind, positive drug parallel control study
试验速览
- 阶段
- 1 期
- 状态
- 招募中
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional study
入排标准
- 年龄范围
- 18 至 65（—）
- 性别
- All
入选标准
- •(1) course of 36 hours or less;
- •(2) temperature is 37.5 degrees C or higher with flu-like symptoms and has a history of epidemiology;
- •(3) test positive for influenza virus antigen;
- •(4) the age of 18 years old or more, < 65 years old;
- •(5) in the diagnosis and treatment scheme (2019) influenza mild of traditional Chinese medicine dialectical;
- •(6) agreed to sign a consent form.
排除标准
- •(1) Mental illness, or other cooperation or not let collaborators.
- •(2) for nearly three months to participate in other subjects.
- •(3) the researcher has the following flu complications in patients with known risk factors:
- •A) pregnancy women or puerperal women;
- •B) chronic respiratory diseases, including COPD and asthma;
- •C) the nervous system diseases and neurodevelopmental disorders, including brain, spinal cord, peripheral nerve and muscle disease (for example, cerebral palsy, epilepsy seizure, stroke, mental retardation, moderate to severe retardation, muscular dystrophy or spinal cord injury (sci).
- •D) heart disease, for example, congenital heart disease, congestive heart failure, or coronary artery disease), not including any other heart related symptoms of high blood pressure;
- •E) blood system diseases;
- •F) the endocrine system diseases (not including glycosylated hemoglobin < 8%;
- •G) kidney disease: creatinine clearance 60 mL/min or less;
- •H) of the liver disease including hepatitis, liver cirrhosis, moderately severe fatty liver, not including the AST and ALT rise less than the upper limit of normal 50 % asymptomatic liver function is unusual).
- •I) metabolic disorders (protein metabolism disorder, sugar metabolic disorder, lipid metabolism disorders, water, electrolyte metabolic disorders, high blood uric acid);
- •J) immune system damage (including patients with immunosuppressive therapy, or cancer or patients with human immunodeficiency virus (HIV) infection);
- •K) in patients with obesity (body mass index (BMI) of 30 or more).
- •(4) the index case weight < 40 kg;
- •(5) has a history of alcohol or drug abuse.
- •(6) within 30 days before the screening, have received the following medications: Baloxavir, palmer peramivir, pull nimmi wei, oseltamivir and zanamivir, rimantadine, Abby dole, amantadine hydrochloride or experimental drugs;
- •(7) 12 months to receive influenza vaccination;
- •(8) into groups of 6 h used antipyretic analgesic drugs;
- •(9) into the group of 12 h application anti-flu features of proprietary Chinese medicine.
研究者
相似试验
尚未招募
不适用
Clinical study for 'Yi-Qin-Fang' decoction in the treatment of uric acid nephropathy by high colon pathwayric acid nephropathyITMCTR1900002859Shenzhen Second People's Hospital
进行中（未招募）
3 期
Homoeopathy in controlling symptoms of flu like illness.CTRI/2018/05/013950Central Council for Research in Homoeopathy New Delhi Ministry of AYUSH Government of India280
尚未招募
不适用
Clinical study on the treatment of influenza and upper respiratory tract infection (febrile virus attack lung syndrome) with Qingfeidayuan granulesITMCTR2100005151Hubei Provincial Hospital of Traditional Chinese Medicine
暂停
不适用
Clinical research on application of the influenza virus detection with the nucleic acid detecting methodInfluenza virus infectionJPRN-UMIN000012178K.K.DNAFORM300
尚未招募
4 期
Efficacy and safety of Chai Yin granules for the treatment of influenza(exogenous wind-heat syndrome): a randomized, double-blind, positive drug control, multicenter clinical trialInfluenzaITMCTR2100004720China-Japan Friendship Hospital